{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:15:35Z","timestamp":1775711735238,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA184585"],"award-info":[{"award-number":["R01CA184585"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K24CA169004"],"award-info":[{"award-number":["K24CA169004"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA120120"],"award-info":[{"award-number":["R01CA120120"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Breast cancer (BC) is one of the most common cancers globally. Genetic testing facilitates screening and informs targeted risk-reduction and treatments. However, genes included in testing panels are from European-ancestry studies. We conducted a pooled case-control analysis in self-identified Hispanic\/Latina women (4178 cases and 4344 controls), using whole exome sequencing and a targeted panel. We tested the association of loss of function (LoF) variants with overall, estrogen receptor (ER)-positive, and ER-negative BC risk. Using logistic regression, we found a strong association of LoF variants in <jats:italic>FANCM<\/jats:italic> with ER-negative BC (<jats:italic>p<\/jats:italic>\u2009=\u20094.1\u2009\u00d7\u200910<jats:sup>\u2212<\/jats:sup>\n            <jats:sup>7<\/jats:sup>), odds ratio [confidence interval]: 6.7 [2.9\u201315.6]). Among known susceptibility genes, <jats:italic>BRCA1<\/jats:italic>, <jats:italic>BRCA2<\/jats:italic>, and <jats:italic>PALB2<\/jats:italic> strongly associated with BC. <jats:italic>FANCM<\/jats:italic> was previously proposed as a possible susceptibility gene for ER-negative BC, but is not routinely tested clinically. Our results demonstrate that <jats:italic>FANCM<\/jats:italic> should be added to BC gene panels.<\/jats:p>","DOI":"10.1038\/s41467-025-60564-0","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:36:43Z","timestamp":1755794203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic\/Latina women"],"prefix":"10.1038","volume":"16","author":[{"given":"Jovia L.","family":"Nierenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron W.","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-001X","authenticated-orcid":false,"given":"Donglei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-818X","authenticated-orcid":false,"given":"Carmina","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-6771","authenticated-orcid":false,"given":"Shu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan Chun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0159-7748","authenticated-orcid":false,"given":"Yiwey","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3179-1151","authenticated-orcid":false,"given":"Laura","family":"Fejerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-7822","authenticated-orcid":false,"given":"Stephen B.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Haiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther M.","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-1175","authenticated-orcid":false,"given":"Lawrence H.","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Torres-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charit\u00e9","family":"Ricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6714-092X","authenticated-orcid":false,"given":"Jeffrey N.","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-2884","authenticated-orcid":false,"given":"Elad","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-0390","authenticated-orcid":false,"given":"Susan L.","family":"Neuhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"60564_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck, N. & Gnant, M. Breast cancer. Lancet 389, 1134\u20131150 (2017).","journal-title":"Lancet"},{"key":"60564_CR2","doi-asserted-by":"publisher","unstructured":"Garcia-Closas, M., Gunsoy, N. B. & Chatterjee, N. Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. J. Natl. Cancer Inst. 106, https:\/\/doi.org\/10.1093\/jnci\/dju305 (2014).","DOI":"10.1093\/jnci\/dju305"},{"key":"60564_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66\u201371 (1994).","journal-title":"Science"},{"key":"60564_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789\u2013792 (1995).","journal-title":"Nature"},{"key":"60564_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman, N. et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39, 165\u2013167 (2007).","journal-title":"Nat. Genet."},{"key":"60564_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233\u20131238 (1990).","journal-title":"Science"},{"key":"60564_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/348747a0","volume":"348","author":"S Srivastava","year":"1990","unstructured":"Srivastava, S., Zou, Z. Q., Pirollo, K., Blattner, W. & Chang, E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348, 747\u2013749 (1990).","journal-title":"Nature"},{"key":"60564_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41571-021-00491-3","volume":"18","author":"WD Foulkes","year":"2021","unstructured":"Foulkes, W. D. The ten genes for breast (and ovarian) cancer susceptibility. Nat. Rev. Clin. Oncol. 18, 259\u2013260 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"60564_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer, H. et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31, 55\u201359 (2002).","journal-title":"Nat. Genet."},{"key":"60564_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","volume":"97","author":"D Thompson","year":"2005","unstructured":"Thompson, D. et al. Cancer risks and mortality in heterozygous ATM mutation carriers. J. Natl Cancer Inst. 97, 813\u2013822 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"60564_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13058-016-0759-4","volume":"18","author":"AD Skol","year":"2016","unstructured":"Skol, A. D., Sasaki, M. M. & Onel, K. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance. Breast Cancer Res.18, 99 (2016).","journal-title":"Breast Cancer Res."},{"key":"60564_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly, M. B. et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl Compr. Cancer Netw. 19, 77\u2013102 (2021).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"60564_CR13","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton, D. F. et al. Gene-panel sequencing and the prediction of breast-cancer risk. N. Engl. J. Med. 372, 2243\u20132257 (2015).","journal-title":"N. Engl. J. Med."},{"key":"60564_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2019.10987","volume":"322","author":"USPST Force","year":"2019","unstructured":"Force, U. S. P. S. T. et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. JAMA 322, 652\u2013665 (2019).","journal-title":"JAMA"},{"key":"60564_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jama.2014.12483","volume":"312","author":"MC King","year":"2014","unstructured":"King, M. C., Levy-Lahad, E. & Lahad, A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA 312, 1091\u20131092 (2014).","journal-title":"JAMA"},{"key":"60564_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01052-8","volume":"14","author":"L Dorling","year":"2022","unstructured":"Dorling, L. et al. Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Med. 14, 51 (2022).","journal-title":"Genome Med."},{"key":"60564_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu, C. et al. A population-based study of genes previously implicated in breast cancer. N. Engl. J. Med. 384, 440\u2013451 (2021).","journal-title":"N. Engl. J. Med."},{"key":"60564_CR18","first-page":"425","volume":"68","author":"KD Miller","year":"2018","unstructured":"Miller, K. D. et al. Cancer statistics for Hispanics\/Latinos, 2018. CA Cancer J. Clin. 68, 425\u2013445 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"60564_CR19","doi-asserted-by":"publisher","first-page":"8954","DOI":"10.1073\/pnas.0914618107","volume":"107","author":"K Bryc","year":"2010","unstructured":"Bryc, K. et al. Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic\/Latino populations. Proc. Natl Acad. Sci. USA 107, 8954\u20138961 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60564_CR20","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2105\/AJPH.2005.068668","volume":"95","author":"E Gonzalez Burchard","year":"2005","unstructured":"Gonzalez Burchard, E. et al. Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am. J. Public Health 95, 2161\u20132168 (2005).","journal-title":"Am. J. Public Health"},{"key":"60564_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6260","volume":"5","author":"L Fejerman","year":"2014","unstructured":"Fejerman, L. et al. Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. Nat. Commun. 5, 5260 (2014).","journal-title":"Nat. Commun."},{"key":"60564_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00317-6","volume":"7","author":"JS Herzog","year":"2021","unstructured":"Herzog, J. S. et al. Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America. NPJ Breast Cancer 7, 107 (2021).","journal-title":"NPJ Breast Cancer"},{"key":"60564_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","volume":"31","author":"JN Weitzel","year":"2013","unstructured":"Weitzel, J. N. et al. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J. Clin. Oncol. 31, 210\u2013216 (2013).","journal-title":"J. Clin. Oncol."},{"key":"60564_CR24","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/cncr.32083","volume":"125","author":"JN Weitzel","year":"2019","unstructured":"Weitzel, J. N. et al. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer 125, 2829\u20132836 (2019).","journal-title":"Cancer"},{"key":"60564_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-S3-S3","volume":"14","author":"H Carter","year":"2013","unstructured":"Carter, H., Douville, C., Stenson, P. D., Cooper, D. N. & Karchin, R. Identifying Mendelian disease genes with the variant effect scoring tool. BMC Genomics 14, S3 (2013).","journal-title":"BMC Genomics"},{"key":"60564_CR26","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.1407909111","volume":"111","author":"JI Kiiski","year":"2014","unstructured":"Kiiski, J. I. et al. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc. Natl Acad. Sci. USA 111, 15172\u201315177 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60564_CR27","doi-asserted-by":"publisher","first-page":"5345-","DOI":"10.1093\/hmg\/ddv251","volume":"24","author":"P Peterlongo","year":"2015","unstructured":"Peterlongo, P. et al. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Hum. Mol. Genet. 24, 5345-\u201355355 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"60564_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-017-4388-0","volume":"166","author":"JI Kiiski","year":"2017","unstructured":"Kiiski, J. I. et al. FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population. Breast Cancer Res. Treat. 166, 217\u2013226 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"60564_CR29","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2016.5592","volume":"3","author":"G Neidhardt","year":"2017","unstructured":"Neidhardt, G. et al. Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer. JAMA Oncol. 3, 1245\u20131248 (2017).","journal-title":"JAMA Oncol."},{"key":"60564_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-019-0127-5","volume":"5","author":"G Figlioli","year":"2019","unstructured":"Figlioli, G. et al. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer 5, 38 (2019).","journal-title":"NPJ Breast Cancer"},{"key":"60564_CR31","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1002\/ijc.30394","volume":"139","author":"JI Kiiski","year":"2016","unstructured":"Kiiski, J. I. et al. FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome. Int. J. Cancer 139, 2760\u20132770 (2016).","journal-title":"Int. J. Cancer"},{"key":"60564_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-018-0524-x","volume":"19","author":"T Nguyen-Dumont","year":"2018","unstructured":"Nguyen-Dumont, T. et al. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine. BMC Med Genet. 19, 12 (2018).","journal-title":"BMC Med Genet."},{"key":"60564_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-015-3457-5","volume":"152","author":"MU Rashid","year":"2015","unstructured":"Rashid, M. U., Muhammad, N., Khan, F. A. & Hamann, U. Absence of the FANCM c.5101C>T mutation in BRCA1\/2-negative triple-negative breast cancer patients from Pakistan. Breast Cancer Res. Treat. 152, 229\u2013230 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"60564_CR34","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/ijc.31992","volume":"144","author":"S Schubert","year":"2019","unstructured":"Schubert, S. et al. The identification of pathogenic variants in BRCA1\/2 negative, high risk, hereditary breast and\/or ovarian cancer patients: High frequency of FANCM pathogenic variants. Int. J. Cancer 144, 2683\u20132694 (2019).","journal-title":"Int. J. Cancer"},{"key":"60564_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.breast.2017.12.013","volume":"38","author":"V Silvestri","year":"2018","unstructured":"Silvestri, V. et al. A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy. Breast 38, 92\u201397 (2018).","journal-title":"Breast"},{"key":"60564_CR36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/gim.2017.124","volume":"20","author":"M Bogliolo","year":"2018","unstructured":"Bogliolo, M. et al. Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia. Genet Med. 20, 458\u2013463 (2018).","journal-title":"Genet Med."},{"key":"60564_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/EDE.0b013e318181b865","volume":"19","author":"P Kraft","year":"2008","unstructured":"Kraft, P. Curses\u2013winner\u2019s and otherwise\u2013in genetic epidemiology. Epidemiology 19, 649\u2013651 (2008.","journal-title":"Epidemiology"},{"key":"60564_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/biostatistics\/kxn001","volume":"9","author":"H Zhong","year":"2008","unstructured":"Zhong, H. & Prentice, R. L. Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. Biostatistics 9, 621\u2013634 (2008).","journal-title":"Biostatistics"},{"key":"60564_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/gepi.20437","volume":"34","author":"H Zhong","year":"2010","unstructured":"Zhong, H. & Prentice, R. L. Correcting \u201cwinner\u2019s curse\u201d in odds ratios from genomewide association findings for major complex human diseases. Genet Epidemiol. 34, 78\u201391 (2010).","journal-title":"Genet Epidemiol."},{"key":"60564_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1055-9965.EPI-08-0416","volume":"18","author":"O Fletcher","year":"2009","unstructured":"Fletcher, O. et al. Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls. Cancer Epidemiol. Biomark. Prev. 18, 230\u2013234 (2009).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"60564_CR41","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.molcel.2021.03.044","volume":"81","author":"A Panday","year":"2021","unstructured":"Panday, A. et al. FANCM regulates repair pathway choice at stalled replication forks. Mol. Cell 81, 2428\u20132444.e2426 (2021).","journal-title":"Mol. Cell"},{"key":"60564_CR42","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/hmg\/dds013","volume":"21","author":"AN Blackford","year":"2012","unstructured":"Blackford, A. N. et al. The DNA translocase activity of FANCM protects stalled replication forks. Hum. Mol. Genet. 21, 2005\u20132016 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"60564_CR43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15252\/embj.201693860","volume":"35","author":"J Michl","year":"2016","unstructured":"Michl, J., Zimmer, J. & Tarsounas, M. Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J. 35, 909\u2013923 (2016).","journal-title":"EMBO J."},{"key":"60564_CR44","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch, F. J. et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 3, 1190\u20131196 (2017).","journal-title":"JAMA Oncol."},{"key":"60564_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2023.9526","volume":"330","author":"AW Kurian","year":"2023","unstructured":"Kurian, A. W. et al. Germline genetic testing after cancer diagnosis. JAMA 330, 43\u201351 (2023).","journal-title":"JAMA"},{"key":"60564_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/BD-2010-0319","volume":"32","author":"GL Gierach","year":"2010","unstructured":"Gierach, G. L., Burke, A. & Anderson, W. F. Epidemiology of triple negative breast cancers. Breast Dis. 32, 5\u201324 (2010).","journal-title":"Breast Dis."},{"key":"60564_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.dnarep.2014.12.003","volume":"26","author":"C Stoepker","year":"2015","unstructured":"Stoepker, C. et al. DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity. DNA Repair 26, 54\u201364 (2015).","journal-title":"DNA Repair"},{"key":"60564_CR48","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/aje\/148.7.683","volume":"148","author":"FD Gilliland","year":"1998","unstructured":"Gilliland, F. D. et al. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women\u2019s Health Study. Am. J. Epidemiol. 148, 683\u2013692 (1998).","journal-title":"Am. J. Epidemiol."},{"key":"60564_CR49","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2105\/AJPH.84.6.971","volume":"84","author":"EJ Perez-Stable","year":"1994","unstructured":"Perez-Stable, E. J., Marin, G. & Marin, B. V. Behavioral risk factors: a comparison of Latinos and non-Latino whites in San Francisco. Am. J. Public Health 84, 971\u2013976 (1994).","journal-title":"Am. J. Public Health"},{"key":"60564_CR50","first-page":"795","volume":"11","author":"MC Pike","year":"2002","unstructured":"Pike, M. C. et al. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol. Biomark. Prev. 11, 795\u2013800 (2002).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"60564_CR51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584\u2013591 (2019).","journal-title":"Nat. Genet."},{"key":"60564_CR52","doi-asserted-by":"publisher","first-page":"9723","DOI":"10.1158\/0008-5472.CAN-08-2039","volume":"68","author":"L Fejerman","year":"2008","unstructured":"Fejerman, L. et al. Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res. 68, 9723\u20139728 (2008).","journal-title":"Cancer Res."},{"key":"60564_CR53","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/1055-9965.EPI-09-1193","volume":"19","author":"L Fejerman","year":"2010","unstructured":"Fejerman, L. et al. European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol. Biomark. Prev. 19, 1074\u20131082 (2010).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"60564_CR54","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/hmg\/ddr617","volume":"21","author":"L Fejerman","year":"2012","unstructured":"Fejerman, L. et al. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum. Mol. Genet. 21, 1907\u20131917 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"60564_CR55","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41588-023-01466-z","volume":"55","author":"N Wilcox","year":"2023","unstructured":"Wilcox, N. et al. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. Nat. Genet. 55, 1435\u20131439 (2023).","journal-title":"Nat. Genet."},{"key":"60564_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"},{"key":"60564_CR57","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"60564_CR58","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"60564_CR59","doi-asserted-by":"publisher","first-page":"e1002554","DOI":"10.1371\/journal.pgen.1002554","volume":"8","author":"JM Galanter","year":"2012","unstructured":"Galanter, J. M. et al. Development of a panel of genome-wide ancestry informative markers to study admixture throughout the Americas. PLoS Genet. 8, e1002554 (2012).","journal-title":"PLoS Genet."},{"key":"60564_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"60564_CR61","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1101\/gr.094052.109","volume":"19","author":"DH Alexander","year":"2009","unstructured":"Alexander, D. H., Novembre, J. & Lange, K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res. 19, 1655\u20131664 (2009).","journal-title":"Genome Res."},{"key":"60564_CR62","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"60564_CR63","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","volume":"91","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am. J. Hum. Genet. 91, 224\u2013237 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"60564_CR64","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/biostatistics\/kxs014","volume":"13","author":"S Lee","year":"2012","unstructured":"Lee, S., Wu, M. C. & Lin, X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13, 762\u2013775 (2012).","journal-title":"Biostatistics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60564-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:06:59Z","timestamp":1757416019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60564-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60564"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60564-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.L.N. is an employee and shareholder at BridgeBio Pharma, this work was done prior to her work at BridgeBio Pharma. J.N.W. is a consultant to Natera, MyOme and Cancer IQ, holds equity in Natera and is a co-founder of Novi Health. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7816"}}